Use our chat feature to speak with one of our expert consultants who can help you identify if medical cannabis can help you.
6 min read
Lucy MacKinnon
World AIDS Day takes place every year on the 1st of December, and has done since 1988. We’d like to honour this year's campaign by raising the awareness of one treatment option many affected by HIV aren’t even aware is available to them: medical cannabis.
While the symptoms AIDS and HIV cause are conventionally managed using multifaceted treatment plans that couple antiretroviral therapies with general medicines like painkillers, antidepressants, and often sleeping aids, these aren’t effective for everyone, and they can come with a long list of side effects.
However, unbeknownst to many, since 2018 medical cannabis has been available as an alternative option through private healthcare clinics like Releaf, when traditional approaches have proven ineffective.
And our own research suggests, despite the intertwining history of HIV and medical cannabis, only around 2% of UK adults are aware cannabis-based medicines can be prescribed to help manage the symptoms of HIV.
So, we thought now was the perfect time to give a recap of the potential of medical cannabis in HIV/AIDS symptom management.
But first, here’s a bit more on World AIDS Day:
As a global movement designed to unite people all around the world affected by HIV, World AIDS Day campaigns to end the stigma associated with the virus, spreads awareness of the support available calling for strength and solidarity, and pays tribute to those no longer with us.
And this is an extremely important cause. Over the last 40 years, more than 35 million people have lost their lives to HIV/AIDS, making it one of the most destructive pandemics in history.
But now, thanks to developments in medical care and the proactive approach taken to prevent transmission, diagnosis rates are increasing, and those with the virus can, and are expected to, live long, happy, and healthy lives because of the support and treatments now available.
HIV, or human immunodeficiency virus, transmits from person to person through bodily fluids, damaging cells in the immune system and weakening its ability to fight everyday illnesses, diseases, and infections.
Acquired immunodeficiency virus (AIDS) meanwhile, is the name given to infections and illnesses that occur after an immune system has been severely damaged by HIV. AIDS cannot be transmitted from person to person, and now thanks to medical improvements most people with HIV will not develop any AIDS-related illnesses.
Last year, just over 6000 people received the news they had been diagnosed with HIV in England, and it’s estimated around 100,000 individuals were using HIV care services in England during 2023.
Other estimates suggest more than 4,000 others are also living with HIV, but they are not yet aware, and are yet to be diagnosed.
Figures for those living with HIV in the UK vary, but globally it's estimated currently around 38 million people are living with HIV/AIDS.
HIV/AIDS treatment plans vary from person to person depending on the symptoms they encounter, but as a standard If HIV is caught within the first 72 hours of transmission Post-exposure prophylaxis (PEP) is recommended as an emergency treatment.
After that, regular blood tests are required to monitor the progression of the virus’ infection, and different antiretroviral therapies (ART) are prescribed, such as Atripla and Dovato.
ARTs are usually by accompanied by conventional or generic medicines designed to target specific symptoms, such as opioid-based drugs to manage pain, melatonin for trouble sleeping, and SSRIs to manage mental health concerns.
Medical cannabis has shown to interact with a number of HIV symptoms, which may be why 27% of people with HIV in the UK have tried using medical cannabis for symptom management before.
Now these options are legally accessible in the UK through specialist doctors like those that work at Releaf and there is strong real-world evidence to demonstrate its potential in HIV-related pain management, and mental health support.
For example, one survey found of those who use medical cannabis as part of their HIV treatment said it made a difference to their; appetite (97%), levels of anxiety (93%), depression (86%) and nausea (93%), paresthesia (85%) as well as muscle (94%) and nerve pain (90%).
Another study, this time a small-scale randomised crossover clinical trial, found that at a tolerable dose, medical cannabis significantly reduced the intensity HIV-associated neuropathic pain compared to the placebo tested.
While more research is required to further evidence the interaction between medical cannabis and HIV related symptoms, cannabis-based treatments are generally well tolerated and come with minimal side effects when accurately dosed.
HIV and medical cannabis have a long intertwining history, with many activists who campaigned for its legalisation in the western world inspired by the therapeutic potential it offers those with HIV-associated weight and appetite loss, pain and mental health concerns.
In the US, grassroot activists like Dennis Peron and Mary Rathburn campaigned for political and societal changes towards during the AIDS epidemic after seeing the effects that cannabis was having on their friends and loved ones with HIV. At the same time, they distrusted cannabis edibles and medical cannabis to those that needed it most, starting a co-op relying on donations to help those suffering, despite facing numerous arrests each.
In the early 90s after tireless campaigning, Proposition P was passed in San Francisco in 1991, which recommended the State of California make medical marijuana available to those who required it, and protect the physicians that prescribed it. In November 1996 The Compassionate Use Act, also known as California Proposition 215, came into effect, legalising the use of cannabis for medicinal purposes.
22 years later, the UK followed suit, legalising medical cannabis for patients who have found traditional treatments to be ineffective, including those with HIV.
If you or a loved one are living with HIV, and you’d like to find out more about whether medical cannabis may be able to help, we’re here to support you along the journey.
Our online eligibility checker makes assessing your suitability an ease, simply fill our online checker and health questionnaires and sit back while our doctors assess your medical records.
If it appears medical cannabis may be an appropriate approach, you can schedule in for an initial consultation with one of our specialists to discuss the options available to you. To make it even easier, our Releaf+ subscription plans ensures cost-predictability for future treatments, regular virtual check ins with the clinical team, and free, safe and secure medication delivery - to make sure you get the very best from your treatment.
For more information about how it works, or to read up more on medical cannabis before making a decision, head over to our blog, education, or FAQ pages.
It is important to seek medical advice before starting any new treatments. The patient advisors at Releaf are available to provide expert advice and support. Alternatively, click here to book a consultation with one of our specialist doctors.
Get comprehensive care, convenience, and confidence with an all-in-one treatment plan.
Am I eligible?With five years of journalism and healthcare content creation under her belt, Lucy strives to improve medical cannabis awareness and access in the UK by producing high quality, credible content.
All of our articles are written by medical cannabis experts, guided by strict sourcing guidelines, and reference peer-reviewed studies and credible academic research. Our expert clinical team and compliance specialists provide valuable insights to ensure accuracy when required. Learn more in our editorial policy.
Need more help?
Around the world, 1.3 billion, or 1 in 6, people live with a disability - yet many face barriers when accessing adequate healthcare services. At Releaf, it's important to us to participate in events like International Day of Persons with Disabilities, and so that’s exactly what we’re doing.
Lucy MacKinnon
Last year, our representative research found 68% of UK adults would consider medical cannabis treatment if their doctor recommended it, but around 1 in 4 said they would be apprehensive about, and perhaps discouraged by, the costs involved.
Lucy MacKinnon
Last week, it was Road Safety Awareness Week, an important annual event that aims to raise awareness around road safety and improve funding and care for victims of road traffic accidents.
Emily Ledger
